Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature.

Liu, Yen-TingYen-TingLiuYI-HSING CHENChang, Chen-HanChen-HanChangHSIANG-KUANG LIANG2024-11-152024-11-152024https://scholars.lib.ntu.edu.tw/handle/123456789/723087entrueFGFR3 fusionneuro-oncologypemigatinibprecision medicinerecurrent glioblastomatargeted therapy[SDGs]SDG3Recurrent fibroblast growth factor receptor3 fusion glioblastoma treated with pemigatinib: A case report and review of the literature.journal article10.1093/noajnl/vdae072388456912-s2.0-85195518658